Abstract
Imaging of tuberous sclerosis complex has rapidly evolved over the last decade in association with increased understanding of the disease process and new treatment modalities. Tuberous sclerosis complex is best known for the neurological symptoms and the associated neuroimaging findings, and children with tuberous sclerosis complex require active surveillance of associated abnormalities in the chest, abdomen and pelvis. Common findings that require regular imaging surveillance are angiomyolipomas in the kidneys and lymphangioleiomyomatosis in the chest. However multiple rarer associations have been attributed to tuberous sclerosis complex and should be considered by radiologists reviewing any imaging in these children. In this review the authors discuss the spectrum of imaging findings in people with tuberous sclerosis complex, focusing on MR imaging findings in the chest, abdomen and pelvis.
Similar content being viewed by others
References
Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus Group (2013) Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49:243–254
Caban C, Khan N, Hasbani DM, Crino PB (2017) Genetics of tuberous sclerosis complex: implications for clinical practice. Appl Clin Genet 10:1–8
Roach ES, Gomez MR, Northrup H (1998) Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 13:624–628
O’Callaghan FJ, Shiell AW, Osborne JP, Martyn CN (1998) Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet 351:1490
Sampson JR, Scahill SJ, Stephenson JB et al (1989) Genetic aspects of tuberous sclerosis in the west of Scotland. J Med Genet 26:28–31
Randle SC (2017) Tuberous sclerosis complex: a review. Pediatr Ann 46:e166–e171
Manoukian SB, Kowal DJ (2015) Comprehensive imaging manifestations of tuberous sclerosis. AJR Am J Roentgenol 204:933–943
Au KS, Williams AT, Roach ES et al (2007) Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med 9:88–100
Webb DW, Clarke A, Fryer A, Osborne JP (1996) The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol 135:1–5
Jóźwiak S, Schwartz RA, Janniger CK et al (1998) Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int J Dermatol 37:911–917
Curatolo P, Bombardieri R, Jozwiak S (2008) Tuberous sclerosis. Lancet 372:657–668
Curatolo P, Moavero R, Roberto D, Graziola F (2015) Genotype/phenotype correlations in tuberous sclerosis complex. Semin Pediatr Neurol 22:259–273
Franz DN, Belousova E, Sparagana S et al (2013) Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 381:125–132
Bissler JJ, Kingswood JC, Radzikowska E et al (2013) Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 381:817–824
Krueger DA, Wilfong AA, Holland-Bouley K et al (2013) Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol 74:679–687
Capal JK, Franz DN (2016) Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy. Neuropsychiatr Dis Treat 12:2165–2172
French JA, Lawson JA, Yapici Z et al (2016) Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet 388:2153–2163
Siroky BJ, Towbin AJ, Trout AT et al (2017) Improvement in renal cystic disease of tuberous sclerosis complex after treatment with mammalian target of rapamycin inhibitor. J Pediatr 187:318–322.e2
Koenig MK, Hebert AA, Roberson J et al (2012) Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin. Drugs R D 12:121–126
Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus Group (2013) Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49:255–265
Halpenny D, Snow A, McNeill G, Torreggiani WC (2010) The radiological diagnosis and treatment of renal angiomyolipoma — current status. Clin Radiol 65:99–108
Lopes Vendrami C, Parada Villavicencio C, DeJulio TJ et al (2017) Differentiation of solid renal tumors with multiparametric MR imaging. Radiographics 37:2026–2042
Lienert AR, Nicol D (2012) Renal angiomyolipoma. BJU Int 110 Suppl 4:25–27
Thway K, Fisher C (2015) PEComa: morphology and genetics of a complex tumor family. Ann Diagn Pathol 19:359–368
Katabathina VS, Vikram R, Nagar AM et al (2010) Mesenchymal neoplasms of the kidney in adults: imaging spectrum with radiologic-pathologic correlation. Radiographics 30:1525–1540
Jinzaki M, Silverman SG, Akita H et al (2014) Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging 39:588–604
Fricke BL, Donnelly LF, Casper KA, Bissler JJ (2004) Frequency and imaging appearance of hepatic angiomyolipomas in pediatric and adult patients with tuberous sclerosis. AJR Am J Roentgenol 182:1027–1030
Lu J, Xiong X-Z, Cheng N-S (2014) Education and imaging. Hepatobiliary and pancreatic: hepatic and renal angiomyolipomas associated with tuberous sclerosis complex. J Gastroenterol Hepatol 29:421
Asayama Y, Fukuya T, Honda H et al (1998) Chronic expanding hematoma of the spleen caused by angiomyolipoma in a patient with tuberous sclerosis. Abdom Imaging 23:527–530
Hulbert JC, Graf R (1983) Involvement of the spleen by renal angiomyolipoma: metastasis or multicentricity? J Urol 130:328–329
Morita K, Shida Y, Shinozaki K et al (2012) Angiomyolipomas of the mediastinum and the lung. J Thorac Imaging 27:W21–W23
Bissler JJ, Kingswood JC (2004) Renal angiomyolipomata. Kidney Int 66:924–934
Yamakado K, Tanaka N, Nakagawa T et al (2002) Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology 225:78–82
O’Callaghan FJ, Noakes MJ, Martyn CN, Osborne JP (2004) An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int 94:853–857
Ouzaid I, Autorino R, Fatica R et al (2014) Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention. BJU Int 114:412–417
Dickinson M, Ruckle H, Beaghler M, Hadley HR (1998) Renal angiomyolipoma: optimal treatment based on size and symptoms. Clin Nephrol 49:281–286
Amin S, Lux A, Calder N et al (2017) Causes of mortality in individuals with tuberous sclerosis complex. Dev Med Child Neurol 59:612–617
Ramamurthy NK, Moosavi B, McInnes MDF et al (2015) Multiparametric MRI of solid renal masses: pearls and pitfalls. Clin Radiol 70:304–316
Chung MS, Choi HJ, Kim M-H, Cho K-S (2014) Comparison of T2-weighted MRI with and without fat suppression for differentiating renal angiomyolipomas without visible fat from other renal tumors. AJR Am J Roentgenol 202:765–771
Bissler JJ, McCormack FX, Young LR et al (2008) Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 358:140–151
Casper KA, Donnelly LF, Chen B, Bissler JJ (2002) Tuberous sclerosis complex: renal imaging findings. Radiology 225:451–456
Ewalt DH, Sheffield E, Sparagana SP et al (1998) Renal lesion growth in children with tuberous sclerosis complex. J Urol 160:141–145
Dillman JR, Trout AT, Smith EA, Towbin AJ (2017) Hereditary renal cystic disorders: imaging of the kidneys and beyond. Radiographics 37:924–946
Brook-Carter PT, Peral B, Ward CJ et al (1994) Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease — a contiguous gene syndrome. Nat Genet 8:328–332
Back SJ, Andronikou S, Kilborn T et al (2015) Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome. Pediatr Radiol 45:386–395
Black ME, Hedgire SS, Camposano S et al (2012) Hepatic manifestations of tuberous sclerosis complex: a genotypic and phenotypic analysis. Clin Genet 82:552–557
Tello R, Blickman JG, Buonomo C, Herrin J (1998) Meta analysis of the relationship between tuberous sclerosis complex and renal cell carcinoma. Eur J Radiol 27:131–138
National Cancer Institute (2014) Cancer stat facts: kidney and renal pelvis cancer. https://seer.cancer.gov/statfacts/html/kidrp.html. Accessed 12 Nov 2017
Rakowski SK, Winterkorn EB, Paul E et al (2006) Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int 70:1777–1782
Lendvay TS, Broecker B, Smith EA (2002) Renal cell carcinoma in a 2-year-old child with tuberous sclerosis. J Urol 168:1131–1132
Washecka R, Hanna M (1991) Malignant renal tumors in tuberous sclerosis. Urology 37:340–343
Crino PB, Nathanson KL, Henske EP (2006) The tuberous sclerosis complex. N Engl J Med 355:1345–1356
Guo J, Tretiakova MS, Troxell ML et al (2014) Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients. Am J Surg Pathol 38:1457–1467
Yang P, Cornejo KM, Sadow PM et al (2014) Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol 38:895–909
Bjornsson J, Short MP, Kwiatkowski DJ, Henske EP (1996) Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features. Am J Pathol 149:1201–1208
Li H, Liang L, Li A et al (2017) Monoexponential, biexponential, and stretched exponential diffusion-weighted imaging models: quantitative biomarkers for differentiating renal clear cell carcinoma and minimal fat angiomyolipoma. J Magn Reson Imaging 46:240–247
Ding Y, Zeng M, Rao S et al (2016) Comparison of biexponential and monoexponential model of diffusion-weighted imaging for distinguishing between common renal cell carcinoma and fat poor angiomyolipoma. Korean J Radiol 17:853–863
Darden JW, Teeslink R, Parrish A (1975) Hamartoma of the spleen: a manifestation of tuberous sclerosis. Am Surg 41:564–566
Ramani M, Reinhold C, Semelka RC et al (1997) Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions. Radiology 202:166–172
Torres GM, Terry NL, Mergo PJ, Ros PR (1995) MR imaging of the spleen. Magn Reson Imaging Clin N Am 3:39–50
Paterson A, Frush DP, Donnelly LF et al (1999) A pattern-oriented approach to splenic imaging in infants and children. Radiographics 19:1465–1485
Wang J-H, Ma X-L, Ren F-Y et al (2013) Multi-modality imaging findings of splenic hamartoma: a report of nine cases and review of the literature. Abdom Imaging 38:154–162
Arva NC, Pappas JG, Bhatla T et al (2012) Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis — case report and review of the literature. Am J Surg Pathol 36:149–153
Díaz Díaz D, Ibarrola C, Goméz Sanz R et al (2012) Neuroendocrine tumor of the pancreas in a patient with tuberous sclerosis: a case report and review of the literature. Int J Surg Pathol 20:390–395
Larson AM, Hedgire SS, Deshpande V et al (2012) Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex. Clin Genet 82:558–563
Koc G, Sugimoto S, Kuperman R et al (2017) Pancreatic tumors in children and young adults with tuberous sclerosis complex. Pediatr Radiol 47:39–45
Buehler D, Weisman P (2017) Soft tissue tumors of uncertain histogenesis: a review for dermatopathologists. Clin Lab Med 37:647–671
Fletcher CDM, Krishnan Unni K, Mertens F (2002) Pathology and genetics of tumours of soft tissue and bone. IARC, Lyon
Martignoni G, Pea M, Reghellin D et al (2008) PEComas: the past, the present and the future. Virchows Arch 452:119–132
Bonetti F, Pea M, Martignoni G, Zamboni G (1992) PEC and sugar. Am J Surg Pathol 16:307–308
Agaram NP, Sung Y-S, Zhang L et al (2015) Dichotomy of genetic abnormalities in PEComas with therapeutic implications. Am J Surg Pathol 39:813–825
Hartley CP, Kwiatkowski DJ, Hamieh L et al (2016) Pancreatic PEComa is a novel member of the family of tuberous sclerosis complex-associated tumors: case report and review of the literature. Virchows Arch 469:707–710
Okamoto S, Komura M, Terao Y et al (2017) Pneumothorax caused by cystic and nodular lung metastases from a malignant uterine perivascular epithelioid cell tumor (PEComa). Respir Med Case Rep 22:77–82
Starbuck KD, Drake RD, Budd GT, Rose PG (2016) Treatment of advanced malignant uterine perivascular epithelioid cell tumor with mTOR inhibitors: single-institution experience and review of the literature. Anticancer Res 36:6161–6164
Tan Y, Zhang H, Xiao E-H (2013) Perivascular epithelioid cell tumour: dynamic CT, MRI and clinicopathological characteristics — analysis of 32 cases and review of the literature. Clin Radiol 68:555–561
Calcagni G, Gesualdo F, Tamisier D et al (2008) Arterial aneurysms and tuberous sclerosis: a classic but little known association. Pediatr Radiol 38:795–797
Jost CJ, Gloviczki P, Edwards WD et al (2001) Aortic aneurysms in children and young adults with tuberous sclerosis: report of two cases and review of the literature. J Vasc Surg 33:639–642
Arora A, Bansal K, Sureka B (2015) Vascular, gastrointestinal, and urogenital associations of tuberous sclerosis: classic but less known. AJR Am J Roentgenol 205:W566
Rolfes DB, Towbin R, Bove KE (1985) Vascular dysplasia in a child with tuberous sclerosis. Pediatr Pathol 3:359–373
Dunet V, Qanadli SD, Lazor R (2013) Beigelman-Aubry C (2013) multiple pulmonary artery aneurysms in tuberous sclerosis complex. BMJ Case Rep. https://doi.org/10.1136/bcr-2012-007911
Wong H, Hadi M, Khoury T et al (2006) Management of severe hypertension in a child with tuberous sclerosis-related major vascular abnormalities. J Hypertens 24:597–599
Kimura Y, Sugimura H, Toda M et al (2005) A case of a 2-year-old boy with tuberous sclerosis complicated with descending aortic aneurysm. Pediatr Int 47:224–226
Patiño Bahena E, Calderón-Colmenero J, Buendía A, Juanico A (2005) Giant aortic aneurysm and rhabdomyomas in infant with tuberous sclerosis (case report). Arch Cardiol Mex 75:448–450
Moon S-B, Shin W-Y, Park Y-J, Kim S-J (2009) An abdominal aortic aneurysm in an 8-month-old girl with tuberous sclerosis. Eur J Vasc Endovasc Surg 37:569–571
Carette M-F, Antoine M, Bazelly B et al (2006) Primary pulmonary artery aneurysm in tuberous sclerosis: CT, angiography and pathological study. Eur Radiol 16:2369–2370
Burrows NJ, Johnson SR (2004) Pulmonary artery aneurysm and tuberous sclerosis. Thorax 59:86
Hyman MH, Whittemore VH (2000) National Institutes of Health consensus conference: tuberous sclerosis complex. Arch Neurol 57:662–665
Salerno AE, Marsenic O, Meyers KEC et al (2010) Vascular involvement in tuberous sclerosis. Pediatr Nephrol 25:1555–1561
Flynn PM, Robinson MB, Stapleton FB et al (1984) Coarctation of the aorta and renal artery stenosis in tuberous sclerosis. Pediatr Radiol 14:337–339
Maruyama H, Ohbayashi C, Hino O et al (2001) Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2. Pathol Int 51:585–594
Castro M, Shepherd CW, Gomez MR et al (1995) Pulmonary tuberous sclerosis. Chest 107:189–195
Taveira-DaSilva AM, Pacheco-Rodriguez G, Moss J (2010) The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis. Lymphat Res Biol 8:9–19
Johnson SR, Cordier JF, Lazor R et al (2010) European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J 35:14–26
Darling TN, Pacheco-Rodriguez G, Gorio A et al (2010) Lymphangioleiomyomatosis and TSC2−/− cells. Lymphat Res Biol 8:59–69
Glasgow CG, Taveira-DaSilva A, Pacheco-Rodriguez G et al (2009) Involvement of lymphatics in lymphangioleiomyomatosis. Lymphat Res Biol 7:221–228
Di Marco F, Terraneo S, Imeri G et al (2016) Women with TSC: relationship between clinical, lung function and radiological features in a genotyped population investigated for lymphangioleiomyomatosis. PLoS One 11:e0155331
Franz DN, Brody A, Meyer C et al (2001) Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med 164:661–668
Costello LC, Hartman TE, Ryu JH (2000) High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc 75:591–594
Moss J, Avila NA, Barnes PM et al (2001) Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med 164:669–671
Taylor JR, Ryu J, Colby TV, Raffin TA (1990) Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med 323:1254–1260
Hammes SR, Krymskaya VP (2013) Targeted approaches toward understanding and treating pulmonary lymphangioleiomyomatosis (LAM). Horm Cancer 4:70–77
Umeoka S, Koyama T, Miki Y et al (2008) Pictorial review of tuberous sclerosis in various organs. Radiographics 28:e32
Tobino K, Johkoh T, Fujimoto K et al (2015) Computed tomographic features of lymphangioleiomyomatosis: evaluation in 138 patients. Eur J Radiol 84:534–541
von Ranke FM, Zanetti G, e Silva JLP et al (2015) Tuberous sclerosis complex: state-of-the-art review with a focus on pulmonary involvement. Lung 193:619–627
Crausman RS, Lynch DA, Mortenson RL et al (1996) Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis. Chest 109:131–137
King MA (1996) MR diagnosis of lymphangioleiomyomatosis: visibility of pulmonary cysts on spin-echo images. Magn Reson Imaging 14:361–363
Popper HH, Juettner-Smolle FM, Pongratz MG (1991) Micronodular hyperplasia of type II pneumocytes — a new lung lesion associated with tuberous sclerosis. Histopathology 18:347–354
Guinee D, Singh R, Azumi N et al (1995) Multifocal micronodular pneumocyte hyperplasia: a distinctive pulmonary manifestation of tuberous sclerosis. Mod Pathol 8:902–906
Avila NA, Dwyer AJ, Rabel A, Moss J (2007) Sporadic lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis: comparison of CT features. Radiology 242:277–285
Taniguchi H, Abo H, Uchiyama A, Noto H (2016) Multifocal micronodular pneumocyte hyperplasia with tuberous sclerosis. Intern Med 55:3407–3408
Ristagno RL, Biddinger PW, Pina EM, Meyer CA (2005) Multifocal micronodular pneumocyte hyperplasia in tuberous sclerosis. AJR Am J Roentgenol 184:S37–S39
Kobashi Y, Sugiu T, Mouri K et al (2008) Multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis: differentiation from multiple atypical adenomatous hyperplasia. Jpn J Clin Oncol 38:451–454
Datta AN, Hahn CD, Sahin M (2008) Clinical presentation and diagnosis of tuberous sclerosis complex in infancy. J Child Neurol 23:268–273
Beghetti M, Gow RM, Haney I et al (1997) Pediatric primary benign cardiac tumors: a 15-year review. Am Heart J 134:1107–1114
Grebenc ML, Rosado de Christenson ML, Burke AP et al (2000) Primary cardiac and pericardial neoplasms: radiologic-pathologic correlation. Radiographics 20:1073–1103
Jóźwiak S, Kotulska K, Kasprzyk-Obara J et al (2006) Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex. Pediatrics 118:e1146–e1151
Harding CO, Pagon RA (1990) Incidence of tuberous sclerosis in patients with cardiac rhabdomyoma. Am J Med Genet 37:443–446
Jóźwiak S, Kawalec W, Dłuzewska J et al (1994) Cardiac tumours in tuberous sclerosis: their incidence and course. Eur J Pediatr 153:155–157
Beroukhim RS, Prakash A, Valsangiacomo Buechel ER et al (2011) Characterization of cardiac tumors in children by cardiovascular magnetic resonance imaging. J Am Coll Cardiol 58:1044–1054
Shaaya EA, Hirshberg JS, Rabe OT et al (2013) Cardiac fat-containing lesions are common in tuberous sclerosis complex. Am J Med Genet A 161A:1662–1665
Adriaensen MEAPM, Schaefer-Prokop CM, Duyndam DAC et al (2009) Fatty foci in the myocardium in patients with tuberous sclerosis complex: common finding at CT. Radiology 253:359–363
Winterkorn EB, Dodd JD, Inglessis I et al (2007) Tuberous sclerosis complex and myocardial fat-containing lesions: a report of four cases. Clin Genet 71:371–373
Adriaensen MEAPM, van Oosterhout MFM, Feringa HHH et al (2011) Mature fat cells in the myocardium of patients with tuberous sclerosis complex. J Clin Pathol 64:244–245
Connell FC, Gordon K, Brice G et al (2013) The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet 84:303–314
Geffrey AL, Shinnick JE, Staley BA et al (2014) Lymphedema in tuberous sclerosis complex. Am J Med Genet A 164A:1438–1442
Hoshika Y, Hamamoto T, Sato K et al (2013) Prevalence and clinical features of lymphedema in patients with lymphangioleiomyomatosis. Respir Med 107:1253–1259
Hirsch RJ, Silverberg NB, Laude T, Weinberg JM (1999) Tuberous sclerosis associated with congenital lymphedema. Pediatr Dermatol 16:407–408
Voudris KA, Skardoutsou A, Vagiakou EA (2003) Tuberous sclerosis and congenital lymphedema. Pediatr Dermatol 20:371–373
Lucas M, Andrade Y (2011) Congenital lymphedema with tuberous sclerosis and clinical Hirschsprung disease. Pediatr Dermatol 28:194–195
Sukulal K, Namboodiri N (2012) Congenital lymphedema: another unique and gender specific stigmata of tuberous sclerosis? Indian Pediatr 49:845
Cottafava F, Cosso D, Brida di Priò S et al (1986) A case of Bourneville’s tuberous sclerosis with elephantiasis (caused by lymphedema) of the left leg. Minerva Pediatr 38:49–52
Prato G, Mancardi MM, Baglietto MG et al (2014) Congenital segmental lymphedema in tuberous sclerosis complex with associated subependymal giant cell astrocytomas treated with Mammalian target of rapamycin inhibitors. J Child Neurol 29:NP54–NP57
Pollack SF, Geffrey AL, Thiele EA, Shah U (2015) Primary intestinal lymphangiectasia treated with rapamycin in a child with tuberous sclerosis complex (TSC). Am J Med Genet A 167A:2209–2212
Adams DM, Trenor CC 3rd, Hammill AM et al (2016) Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics 137:e20153257
Holt JF, Dickerson WW (1952) The osseous lesions of tuberous sclerosis. Radiology 58:1–7
Boronat S, Barber I, Pargaonkar V et al (2016) Sclerotic bone lesions at abdominal magnetic resonance imaging in children with tuberous sclerosis complex. Pediatr Radiol 46:689–694
Jonard P, Lonneux M, Boland B et al (2001) Tc-99m HDP bone scan showing bone changes in a case of tuberous sclerosis or Bourneville’s disease. Clin Nucl Med 26:50–52
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Drs Franz and Krueger declared potential conflicts of interest.
Rights and permissions
About this article
Cite this article
Morin, C.E., Morin, N.P., Franz, D.N. et al. Thoracoabdominal imaging of tuberous sclerosis. Pediatr Radiol 48, 1307–1323 (2018). https://doi.org/10.1007/s00247-018-4123-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-018-4123-y